Researchers have identified a gene that might make people resistant to the brain eating disease CJD. The study is part of an effort to find ways of combating a possible epidemic caused by eating BSE infected beef ..

Camels aged less than four years might be a major source of Mers, according to new research. An international team looked for evidence of current or past infection in more than 800 dromedary camels. They found..

Researchers at University of California, Los Angeles (UCLA) have developed a new technology that turns a smartphone into a DNA-scanning fluorescent microscope. Lead researcher Aydogan Ozcan, Howard Hughes Medical..

The monitoring of circulating tumor DNA (ctDNA) is a promising technique that may provide clinicians with a faster, cheaper and less invasive way to evaluate the clinical status and response to therapy of cancer patie..

The Gastric Emptying Breath Test (GEBT) is a new noninvasive test to aid in the diagnosis of delayed gastric emptying, known as gastroparesis and has been officially approved. Current tests used to diagnose gastro..

In recent years, growing together with global IVD industry, China IVD industry is increasing at a speed of around 20% every year. According to Evaluat emedtech’s report, at the end of 2018, global IVD market wil..

It may not have made much of an impression with providers when it was unveiled, but the Apple Watch is gaining ground fast, with a new provider-facing app seemingly introduced every day. Now the trendy smartwatch, w..

The results have important implications for the use of cancer therapies that target specific cancer mutations, explains Dr Martin Reck from the Department of Thoracic Oncology at Lung Clinic Grosshansdorf, Germany, wh..

The U.S. Food and Drug Administration today approved the KAMRA inlay, a device implanted in the cornea of one eye (the clear, front surface) to improve near vision in certain patients with presbyopia. It is the first ..

Amgen has won an FDA approval for the heart drug ivabradine, which will hit the market as Corlanor. This is the first approval for a new class of drug aimed at preventing hospitalization for a deteriorating heart, slo..

New research at the University of Aberdeen has identified potential new targets for the treatment of certain types of cancer. This research could lead to the development of new drug therapies tailored to individua..

Myriad’s BRAC Analysis CDx test will be used to identify prospective patients of metastatic pancreatic cancer who could respond to AstraZeneca’s Lynparza AstraZeneca plc (ADR) (NYSE:AZN) and Myriad Gen..

The US Food and Drug Administration (FDA) has approved marketing clearance for the Alere i Strep A test (Alere Inc), the first molecular test that detects group A streptococcus bacteria in throat swab specimens in 8 m..

As next-generation sequencing (NGS) reaches the clinical laboratory, a new analysis by Kalorama Information (New York, NY, USA) finds that small reference laboratories as well as over 50 companies now offer sequencing..

According to a new Frost & Sullivan (Mountain View, CA, USA) analysis, convergence of immunological and molecular tests will help meet growing needs for infectious disease (ID) diagnostics. Although these tests re..

The market for real-time quantitative polymerase chain reaction (qPCR) was valued at about USD 3.2 billion for 2013 according to Kalorama Information (New York, NY, USA) an increase from USD 2.8 billion in 2011. The h..

The global blood industry has experienced strong growth in recent years and growth will remain solid though 2018, according to the new report, "Blood: The Worldwide Market for Blood Products, Blood Testing, Blood..

In China, violence against medical staff has drawn worldwide attention, and occurs for many reasons, as discussed previously. As first-line heath-care workers in China, we think the absence of transparency and mar..

EKF Molecular, of EKF Diagnostics (Cardiff, UK), and Massachusetts General Hospital (MGH; Boston, MA, USA) have entered into a 2-year research collaboration to develop PointMan assays that can effectively detect treat..

Thermo Fisher Scientific (NYSE: TMO) enters into an agreement with GlaxoSmithKline (NYSE: GSK) and Pfizer (NYSE: PFE) to develop a universal next-generation sequencing (NGS) oncology test for solid tumors that will se..